Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
BCAAs wins 1 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Probably helps
7 of 13 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
6 of 10 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both BCAAs and Potassium have evidence — compare verdict strength side-by-side.
5-10g per serving
Before fasted training, During long endurance sessions, Between meals
Powder (2:1:1 ratio)
99-500mg daily from supplements (food provides more)
With food to reduce GI upset, Spread throughout day, During/after exercise for athletes
Potassium Citrate or Potassium Gluconate
24-72 hours post-exercise
During exercise
Ongoing
Immediate
2-4 weeks
1-2 weeks
Long-term
With excess or kidney issues
Systematic review with meta-analysis: Branched-chain amino acid supplementation in liver disease
European journal of clinical investigation (2023) · Meta analysis · n=2308
According to meta-analyses, long-term (at least 6 months) BCAA supplementation in cirrhotic patients significantly improved event-free survival (p = .008; RR .61 95% CI .42-.88) and tended to improve overall survival (p = .05; RR .58 95% CI .34-1.00).
Branched-chain amino acids for people with hepatic encephalopathy
The Cochrane database of systematic reviews (2017) · Meta analysis · n=827
In a random-effects meta-analysis of mortality, we found no difference between BCAA and controls (risk ratio (RR) 0.88, 95% confidence interval (CI) 0.69 to 1.11; 760 participants; 15 trials; moderate quality of evidence).
Causal Relationship Between Branched-Chain Amino Acids and Hypertension: A Mendelian Randomization Study
Journal of the American Heart Association (2024) · Meta analysis · n=845
As suggested by the meta-analysis results, elevated BCAA levels were associated with a higher risk of hypertension (isoleucine: summary odds ratio, 1.26 [95% CI, 1.08-1.47]; leucine: summary odds ratio, 1.28 [95% CI, 1.07-1.52]; valine: summary odds ratio, 1.32 [95% CI, 1.12-1.57]).
Effect of changes in potassium intake on blood pressure: a dose–response meta-analysis of randomized clinical trials (2000–2024)
Clinical Kidney Journal (2024) · Meta analysis · n=2500
Dose-response analysis of RCTs from 2000-2024
Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length
Nutrients (2024) · Meta analysis
Both supplements demonstrated greater reductions in SBP for the general population at lower dosages and longer treatment durations.
Sex-specific associations between sodium and potassium intake and overall and cause-specific mortality: a large prospective U.S. cohort study, systematic review, and updated meta-analysis of cohort studies
BMC medicine (2024) · Meta analysis · n=237036
Meta-analysis examining Potassium efficacy
Evidence limited to resistance training populations. Systematic review found negligible benefits on body composition in athletes. Benefits may be more apparent in caloric deficit or fasted states but data is limited.
AI-estimated from published studies. Interpret as directional guidance.
BCAAs has a higher evidence score (9/10 vs 9/10) and wins in 1 of 3 categories.
For speed up recovery, BCAAs has a higher relevance score (70 vs 50).
No known interactions between BCAAs and Potassium have been documented in our database. However, always consult a healthcare provider before combining supplements.